Blog Post - Johnson & Johnson
Share our Story
Learn about our Company
ABOUT Johnson & Johnson
The values that guide our decision making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Companys founding family, crafted Our Credo himself in 1943, just before JohnsonJohnson became a publicly traded company. This was long before anyone ever heard the term corporate social responsibility. Our Credo is more than just a moral compass. We believe its a recipe for business success. The fact that JohnsonJohnson is one of only a handful of companies that have flourished through more than a century of change is proof of that.
CleanMed Europe 2012: Sustainability’s Promise for Business Opportunity and Healthcare Change
JNJ BTW - Our People Our Perspectives
By Momchil Jelev
Policy Assistant, WW Environment, Health & Safety, WW Government Affairs & Policy
When we speak about healthcare in Europe, the word ‘sustainability’ is used often. From the outset of the economic crisis in 2008, policymakers, ministries of health, customers and payers all have focused on sustainable financial systems and sustainable healthcare systems – often as separate paths to achieve results. As budgets are shrinking, innovative ways to maintain current social and healthcare systems for the long term must be employed. As I attended CleanMed Europe recently, I was pleased to see that a broader alternative discussion is emerging- one that marries financial and systemic sustainability in healthcare.
This year, CleanMed returned to Europe for the first time since 2005. As a sponsor, Johnson & Johnson and SterilMed were pleased to attend the conference hosted in Malmo, Sweden and talk with our customers and colleagues about the ways in which we are helping to make hospitals and healthcare more sustainable. We also shared a recently-published whitepaperbased on recent findings, which revealed that our customers across the globe have begun and will continue to demand more sustainable healthcare products.
Key Take-Aways from CleanMed 2012
I saw two main themes running through three days of workshops, debates, panels and informal chats – first, the ‘tactical’ aspects of bringing sustainability to healthcare; and second — the ‘systemic’ shifts required to meet the current and future challenges of healthcare and environment, while resolving the conundrums that challenge Europe’s healthcare and financial systems.
Regarding tactical considerations, CleanMed Europe showcased a number of innovations that are making hospitals and healthcare products more environmentally friendly:
- hospital design
- space and lighting
- PVC-free flooring
- reprocessed single-use devices
- sustainable products that do not compromise safety and efficacy
- hospital environments that promote faster patient recovery times.
On the strategy side, the challenge of sustainability is much broader than greening hospitals or products. Several speakers were convinced that the largest healthcare challenge of the 21st century will be climate change. However, conference participants, inspired by the insightful interventions of Sonia Roschnik (NHS Sustainable Development Unit), agreed that the scope of this issue requires more systemic thinking about the fundamental ways in which we organize healthcare today.
What stuck with me was the idea that ‘the most sustainable hospital is the one that is never built,‘ and the same can certainly be said about healthcare products. Transitioning from a healthcare system based on cure to one based on prevention is the best way to ensure the goal of saving our planet is fully aligned with that of saving people’s lives. Such a paradigm shift will also ensure that our healthcare systems are financially more sustainable while keeping people healthier for a longer period of their lives. In many ways, this challenged participants’ views of healthcare:
- How do we move away from a cure-based system, if current financial incentives in the system are pointing towards the benefits of treating sick people?
- How do we truly adopt prevention and lifestyle change to ensure that less people go to hospitals (of course there will always be a need for some cure as well!)
- How can industry shift from producing products for cure to also offering services for prevention? And would that shift align with the industry’s profit imperatives, including pressure from shareholders?
Many of these questions will probably remain unanswered in the short term, but the critical step of opening the debate has been taken. We all left from CleanMed convinced that the only way to succeed in moving the debate further is to embed sustainability thinking in all discussions about the future of healthcare both in Europe and globally. Johnson & Johnson demonstrated its readiness to step up in this endeavor and we look forward to continuing our work for the betterment of patients, healthcare providers and the environment.
Next Steps
CleanMed 2013, promises to continue inspiring and challenging the short and long-term ideas about making our healthcare systems more wholly sustainable; and so I look forward to seeing you in Oxford September 17-18th 2013. Until then…
Join Us On Twitter:
Justmeans
Facebook
Twitter
Guest
